Lutropin Alfa in Women at Risk of Poor Response
ClinicalTrials.gov · NCT01112358 · Registry updated: 2018-08-28
- Condition / research focus
- Ovarian Stimulation
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Countries with listed sites
- Spain
- Registry dates and results
- Start: 2005-12-07. Completion: 2007-01-30 (may be estimated). Results are posted in this registry.
Products and interventions (5)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- r-FSH (drug) — also listed as: Follitropin alfa; Gonal-F®
- r-hLH (drug) — also listed as: Lutropin alfa; Luveris®
- Analogous GnRH antagonist (drug) — also listed as: Cetrotide®
- r-hCG (drug)
- Progesterone (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.